The kidney and liver diseases.
作者信息
Wilkinson S P
出版信息
J Clin Pathol. 1981 Nov;34(11):1241-4. doi: 10.1136/jcp.34.11.1241.
Abstract
摘要
相似文献
1
The kidney and liver diseases.
J Clin Pathol. 1981 Nov;34(11):1241-4. doi: 10.1136/jcp.34.11.1241.
2
Disorders of water and electrolyte metabolism in liver disease.
Am J Clin Nutr. 1970 Apr;23(4):499-507. doi: 10.1093/ajcn/23.4.499.
3
[Renal changes in chronic liver diseases. I. Morphological definition and histogenetic theories].
Arch Ital Anat Istol Patol. 1968;42(1):5-45.
4
Spectrum of renal tubular damage in renal failure secondary to cirrhosis and fulminant hepatic failure.
J Clin Pathol. 1978 Feb;31(2):101-7. doi: 10.1136/jcp.31.2.101.
5
[On the relation between liver and kidney diseases-the so-called hepatorenal syndrome].
Dtsch Gesundheitsw. 1968 May 9;23(19):865-73.
6
[Kidney involvement in liver diseases. Pathophysiology and clinical course].
Klin Wochenschr. 1983 Oct 17;61(20):1039-47. doi: 10.1007/BF01537502.
7
Ascites and oedema in liver disease.
Br Med J. 1973 Aug 11;3(5875):336-8. doi: 10.1136/bmj.3.5875.336.
8
[Role of endotoxins in renal changes during hepatopathies].
Minerva Med. 1978 Oct 6;69(47):3231-42.
9
[Functional insufficiency in chronic liver disease patients. The hepatorenal syndrome].
Minerva Med. 1987 May 31;78(10):651-4.
10
[Liver diseases and the kidney].
Nihon Shokakibyo Gakkai Zasshi. 1972 Dec;69(12):1325-31.
引用本文的文献
1
The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease.
Br J Clin Pharmacol. 1983 Feb;15(2):245-52. doi: 10.1111/j.1365-2125.1983.tb01493.x.
2
Recombinant human gamma-interferon in primary hepatocellular carcinoma.
J R Soc Med. 1985 Oct;78(10):826-9. doi: 10.1177/014107688507801007.
本文引用的文献
1
Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure.
J Clin Invest. 1967 Aug;46(8):1297-308. doi: 10.1172/JCI105622.
2
Renal function in decompensated cirrhosis of the liver.
Proc Soc Exp Biol Med. 1950 Dec;75(3):822-4. doi: 10.3181/00379727-75-18358.
3
A lesion resembling medullary sponge kidney in patients with congenital hepatic fibrosis.
Clin Radiol. 1962 Apr;13:85-91. doi: 10.1016/s0009-9260(62)80024-5.
4
Absorption of orally administered neomycin and kanamycin; with special reference to patients with severe hepatic and renal disease.
N Engl J Med. 1960 Feb 25;262:380-5. doi: 10.1056/NEJM196002252620802.
5
RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS.
Am J Med. 1965 Aug;39:184-98. doi: 10.1016/0002-9343(65)90041-0.
6
AN EXTRA-ADRENAL FACTOR ESSENTIAL FOR CHRONIC RENAL SODIUM RETENTION IN PRESENCE OF INCREASED SODIUM-RETAINING HORMONE.
Circ Res. 1964 Jan;14:17-31. doi: 10.1161/01.res.14.1.17.
7
EFFECTS OF ENDOTOXIN ON RENAL FUNCTION AND HEMODYNAMICS.
Am J Physiol. 1963 Aug;205:293-7. doi: 10.1152/ajplegacy.1963.205.2.293.
8
The natural history of cirrhosis. I. Survival with esophageal varices.
N Engl J Med. 1963 Feb 28;268:469-73. doi: 10.1056/NEJM196302282680905.
9
"Cirrhotic glomerulosclerosis," a renal lesion associated with hepatic cirrhosis.
Lab Invest. 1959 Sep-Oct;8:962-78.
10
The mechanism of ascites formation in chronic liver disease.
Q J Med. 1961 Apr;30:153-66.
Zotero 插件